To continue getting breaking news and the full stories from The Boston Globe, subscribe today.

The Boston Globe

Business

J&J ordered to pay Boston Scientific $40m over stents

A Johnson & Johnson unit owes Boston Scientific Corp. more than $40 million in damages for intentionally infringing a patent for coronary stents, a federal judge said in a post-trial ruling. Boston Scientific, a Natick-based medical device company, won about $20 million from Cordis Corp. in a May 2011 jury trial in Wilmington, Del. US District Judge Sue Robinson said in an opinion April 13 that Boston Scientific deserved twice that much.

Stay with the story. Get full access to BostonGlobe.com for just 99¢

Unlimited access to BostonGlobe.com for only 99¢ for the first 4 weeks. You can cancel at any time.

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
Get started today

BostonGlobe.comSubscriber Log In

Contact us for help